Trial intelligence / Profile preview

Clomiphene Metabolism and Hormonal Effects in Healthy Males

NCT03028532Phase 1Completed

Start
Mar 2017
Primary completion
Jan 2018
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of clomiphene in secondary hypogonadism (HH) and male infertility. Primary endpoint: Detection window for clomiphene parent compound and metabolites at Day 72. Started Mar 2017; status: completed.

02

Drugs

clomiphene
03

Conditions

secondary hypogonadism (HH)male infertility

Beyond the preview

Go deeper on NCT03028532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03028532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call